Innovative Treatments
The access to clinical trials for a patient is the opportunity to access a new drug in the safest possible conditions, prior to it being marketed. This opportunity is very important in serious and rare diseases for which there is no existing or poor treatment. Due to the EHDS regulation, the patient can selective share their personal electronic health data with a point of care, including services checking eligibility for clinical trials studies.